Cambridge Science Park
Cambridge Science Park was established in 1970 by Trinity College, Cambridge and is Europe's longest-serving and largest centre for commercial research and development.
|Address:||The Management, The Bradfield Centre, Milton Road, Cambridge|
|Membership type:||Corporate 51+ (£1,000+VAT pa)|
Trinity College invests in companies by providing the design and specialist fit-out of facilities in order to facilitate the process and ensure the success of technology transfer. Now home to over 90 hi-tech companies and more than 5,000 personnel, Cambridge Science Park continues to attract new businesses, from small start-ups and spin-outs to subsidiaries of multinational corporations. Companies on the Park include venture capitalists; biotechnology and pharmaceutical research organisations; and technology and telecommunications developers. The Cambridge Science Park is built on 152 acres of land.
The Park provides specialist facilities and services for a range of R&D sectors across a spectrum of sizes to facilitate the organic growth of companies from start-up to floatation. The Science Park also provides businesses and staff with a modern conference centre, bar, restaurant, gym and squash courts.
Cambridge Science Park is managed by Bidwells, the largest independent property consultants' outside of London and ranked 15 in the UK's Top Property Consultants. The firm offers advice from 14 offices throughout the Eastern Region, East Midlands, London and Scotland. Bidwells are acknowledged as regional experts with an in-depth understanding of local market conditions and regular research publications' are provided to enhance the service to our clients. Bidwells' divisions cover all the main property sectors – Commercial, Rural, and Residential. There are also dedicated teams for Building Consultancy, Residential Development and Planning - the Planning Team being the largest in the Eastern Region.
There are more links between Cambridge and China now than ever. Are you aware? Come along to the Bradfield Centre for an evening with Tuspark and Cambridge Science Park on Wednesday 3 October.
27 September 2018Read in full
The Bradfield Centre is dedicated to equipping its members with the support and tools they need to grow their businesses, on top of providing a world class work space to call home. Using the insights and personal networks developed over years of building their own successful tech businesses, The Bradfield team is excited to announce a new partnership with F6S.
5 December 2017Read in full
Trinity College Cambridge is celebrating a major milestone in the construction of one of the UK’s largest innovation centres, delivered in partnership with the Department for Business, Energy and Industrial Strategy and Central Working.
24 October 2016Read in full
Domainex Ltd. (Cambridge, UK) today announced that The US and European Patent Offices have now granted Domainex patents US 8,962,609 and EPA 11738026.1 for the first generation of inhibitor compounds in its lead programme targeting IKK epsilon and TBK1.
11 May 2015Read in full
As a member of One Nucleus, Cambridge Science Park is encouraging companies and individuals involved with life sciences and academia to attend ON Helix, taking place on 14 July 2015 at the Wellcome Trust Conference Centre, Cambridge
27 April 2015Read in full
Dr Dan Longley’s research team at Queen’s University Belfast, and Domainex Ltd., specialists in drug discovery solutionsand translational research support; today announce the latest development in their collaboration to find new treatments for non-small cell lung carcinoma (NSCLC).
20 April 2015Read in full
Cambridge New Therapeutics Forum (Cam NTF) is a new scientific forum open to all scientists interested in research and development of new therapeutics in Cambridge and the local area, including scientists at the University, Addenbrooke’s Hospital, pharmaceutical companies, biotechs, CROs and not-for-profit organisations.
20 February 2015Read in full
ZoBio (Leiden, The Netherlands) and Domainex Ltd. (Cambridge, UK) announce a collaboration with FORMA Therapeutics (Watertown, MA, USA) to provide NMR-based structural biology services for a substantial panel of FORMA drug targets.
9 December 2014Read in full